IPO market abuzz with biotech offerings The buzz is biotech — at least as far as initial public offerings are concerned in the fourth quarter.
Name *
E-mail *
Web site
Comment
Discussion
No comments for “IPO market abuzz with biotech offerings”
Post a comment